Cargando…
1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472460/ http://dx.doi.org/10.1016/j.annonc.2022.07.1704 |
_version_ | 1784789308669952000 |
---|---|
author | Segelov, E. Body, A. Lal, L. Abdulla, H. Turville, S. Naing, Z. Opat, S. Leahy, M. Balendra, J.R. Hamad, N. Mccuaig, R. Rao, S. Lineburg, K. Smith, C. MacIntyre, C.R. Milch, V. Busija, L. Ahern, E.S. |
author_facet | Segelov, E. Body, A. Lal, L. Abdulla, H. Turville, S. Naing, Z. Opat, S. Leahy, M. Balendra, J.R. Hamad, N. Mccuaig, R. Rao, S. Lineburg, K. Smith, C. MacIntyre, C.R. Milch, V. Busija, L. Ahern, E.S. |
author_sort | Segelov, E. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9472460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94724602022-09-14 1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer Segelov, E. Body, A. Lal, L. Abdulla, H. Turville, S. Naing, Z. Opat, S. Leahy, M. Balendra, J.R. Hamad, N. Mccuaig, R. Rao, S. Lineburg, K. Smith, C. MacIntyre, C.R. Milch, V. Busija, L. Ahern, E.S. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-09 2022-09-13 /pmc/articles/PMC9472460/ http://dx.doi.org/10.1016/j.annonc.2022.07.1704 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Segelov, E. Body, A. Lal, L. Abdulla, H. Turville, S. Naing, Z. Opat, S. Leahy, M. Balendra, J.R. Hamad, N. Mccuaig, R. Rao, S. Lineburg, K. Smith, C. MacIntyre, C.R. Milch, V. Busija, L. Ahern, E.S. 1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer |
title | 1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer |
title_full | 1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer |
title_fullStr | 1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer |
title_full_unstemmed | 1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer |
title_short | 1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer |
title_sort | 1611p clinical determinants of sars-cov-2 vaccine response in adults with cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472460/ http://dx.doi.org/10.1016/j.annonc.2022.07.1704 |
work_keys_str_mv | AT segelove 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT bodya 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT lall 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT abdullah 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT turvilles 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT naingz 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT opats 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT leahym 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT balendrajr 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT hamadn 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT mccuaigr 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT raos 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT lineburgk 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT smithc 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT macintyrecr 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT milchv 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT busijal 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer AT ahernes 1611pclinicaldeterminantsofsarscov2vaccineresponseinadultswithcancer |